Globus Medical ROA 2010-2024 | GMED
Current and historical return on assets (ROA) values for Globus Medical (GMED) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Globus Medical ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2024-09-30 | $0.09B | $5.09B | 1.83% |
| 2024-06-30 | $0.04B | $4.99B | 0.80% |
| 2024-03-31 | $0.07B | $4.94B | 1.52% |
| 2023-12-31 | $0.12B | $5.09B | 3.32% |
| 2023-09-30 | $0.16B | $5.36B | 5.36% |
| 2023-06-30 | $0.20B | $2.21B | 9.70% |
| 2023-03-31 | $0.20B | $2.15B | 9.90% |
| 2022-12-31 | $0.19B | $2.08B | 9.54% |
| 2022-09-30 | $0.16B | $1.98B | 7.90% |
| 2022-06-30 | $0.16B | $1.92B | 7.97% |
| 2022-03-31 | $0.14B | $2.00B | 7.38% |
| 2021-12-31 | $0.15B | $1.96B | 8.02% |
| 2021-09-30 | $0.19B | $1.91B | 10.45% |
| 2021-06-30 | $0.18B | $1.83B | 10.84% |
| 2021-03-31 | $0.12B | $1.74B | 7.53% |
| 2020-12-31 | $0.10B | $1.68B | 6.62% |
| 2020-09-30 | $0.10B | $1.54B | 6.31% |
| 2020-06-30 | $0.09B | $1.47B | 6.00% |
| 2020-03-31 | $0.15B | $1.48B | 10.11% |
| 2019-12-31 | $0.16B | $1.53B | 10.86% |
| 2019-09-30 | $0.15B | $1.45B | 10.66% |
| 2019-06-30 | $0.14B | $1.39B | 10.86% |
| 2019-03-31 | $0.15B | $1.34B | 11.83% |
| 2018-12-31 | $0.16B | $1.30B | 12.92% |
| 2018-09-30 | $0.14B | $1.24B | 12.41% |
| 2018-06-30 | $0.14B | $1.19B | 12.17% |
| 2018-03-31 | $0.12B | $1.13B | 11.23% |
| 2017-12-31 | $0.11B | $1.08B | 10.61% |
| 2017-09-30 | $0.11B | $1.04B | 11.02% |
| 2017-06-30 | $0.11B | $1.00B | 11.41% |
| 2017-03-31 | $0.11B | $0.96B | 11.48% |
| 2016-12-31 | $0.10B | $0.93B | 11.75% |
| 2016-09-30 | $0.12B | $0.90B | 13.70% |
| 2016-06-30 | $0.12B | $0.87B | 14.11% |
| 2016-03-31 | $0.12B | $0.84B | 14.32% |
| 2015-12-31 | $0.11B | $0.83B | 14.38% |
| 2015-09-30 | $0.10B | $0.80B | 13.67% |
| 2015-06-30 | $0.10B | $0.77B | 13.99% |
| 2015-03-31 | $0.10B | $0.74B | 14.31% |
| 2014-12-31 | $0.09B | $0.70B | 14.49% |
| 2014-09-30 | $0.09B | $0.65B | 14.16% |
| 2014-06-30 | $0.08B | $0.62B | 14.38% |
| 2014-03-31 | $0.07B | $0.60B | 12.61% |
| 2013-12-31 | $0.07B | $0.57B | 13.18% |
| 2013-09-30 | $0.07B | $0.53B | 13.99% |
| 2013-06-30 | $0.06B | $0.50B | 13.95% |
| 2013-03-31 | $0.08B | $0.47B | 17.84% |
| 2012-12-31 | $0.07B | $0.45B | 18.68% |
| 2012-09-30 | $0.07B | $0.42B | 18.27% |
| 2012-06-30 | $0.07B | $0.37B | 25.88% |
| 2012-03-31 | $0.06B | $0.36B | 36.26% |
| 2011-12-31 | $0.06B | $0.33B | 68.09% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $12.364B | $1.568B |
| Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $214.066B | 26.11 |
| Intuitive Surgical (ISRG) | United States | $211.086B | 110.36 |
| Alcon (ALC) | Switzerland | $41.615B | 27.84 |
| Edwards Lifesciences (EW) | United States | $41.156B | 26.14 |
| IQVIA Holdings (IQV) | United States | $35.821B | 19.74 |
| IDEXX Laboratories (IDXX) | United States | $34.331B | 40.43 |
| DexCom (DXCM) | United States | $32.958B | 49.63 |
| Waters (WAT) | United States | $23.988B | 35.47 |
| STERIS (STE) | Ireland | $20.691B | 23.82 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.710B | 0.00 |
| Hologic (HOLX) | United States | $15.740B | 17.09 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.538B | 13.90 |
| Sysmex ADR (SSMXY) | Japan | $11.726B | 0.00 |
| Penumbra (PEN) | United States | $10.120B | 99.13 |
| Masimo (MASI) | United States | $9.225B | 44.63 |
| Glaukos (GKOS) | United States | $8.623B | 0.00 |
| Teleflex (TFX) | United States | $8.419B | 13.43 |
| Integer Holdings (ITGR) | United States | $4.729B | 26.81 |
| Inari Medical (NARI) | United States | $4.657B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.967B | 0.00 |
| Veracyte (VCYT) | United States | $3.145B | 94.37 |
| Nihon Kohden (NHNKY) | Japan | $2.658B | 20.19 |
| LivaNova (LIVN) | United Kingdom | $2.623B | 15.14 |
| Tandem Diabetes Care (TNDM) | United States | $2.309B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.167B | 19.48 |
| TransMedics (TMDX) | United States | $1.920B | 60.85 |
| Integra LifeSciences Holdings (IART) | United States | $1.860B | 9.72 |
| Alphatec Holdings (ATEC) | United States | $1.641B | 0.00 |
| Artivion (AORT) | United States | $1.288B | 85.33 |
| RxSight (RXST) | United States | $1.225B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.083B | 0.00 |
| OPKO Health (OPK) | United States | $1.003B | 0.00 |
| Paragon 28 (FNA) | United States | $0.911B | 0.00 |
| AxoGen (AXGN) | United States | $0.796B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.758B | 17.88 |
| IRadimed (IRMD) | United States | $0.750B | 40.53 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.732B | 12.44 |
| SiBone (SIBN) | United States | $0.700B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.693B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.658B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.599B | 31.55 |
| Treace Medical Concepts (TMCI) | United States | $0.543B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.503B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.458B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.449B | 0.00 |
| CVRx (CVRX) | United States | $0.428B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.418B | 22.60 |
| ClearPoint Neuro (CLPT) | United States | $0.415B | 0.00 |
| NeuroPace (NPCE) | United States | $0.357B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.273B | 0.00 |
| Inogen (INGN) | United States | $0.249B | 0.00 |
| Accuray (ARAY) | United States | $0.225B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.215B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.187B | 0.00 |
| Nevro (NVRO) | United States | $0.171B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.144B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.108B | 11.51 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| 908 Devices (MASS) | United States | $0.104B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.098B | 0.00 |
| LENSAR (LNSR) | United States | $0.097B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.094B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.088B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| Neuronetics (STIM) | United States | $0.075B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.073B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| InspireMD (NSPR) | Israel | $0.071B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.059B | 30.93 |
| Baird Medical Investment Holdings (BDMD) | $0.058B | 0.00 | |
| EnVVeno Medical (NVNO) | United States | $0.058B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.053B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.050B | 0.00 |
| Spectral AI (MDAI) | United States | $0.036B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.013B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.008B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |